Procyon Advisors LLC Has $4.79 Million Stock Position in Cardinal Health, Inc. $CAH

Procyon Advisors LLC grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 33.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 22,691 shares of the company’s stock after acquiring an additional 5,666 shares during the period. Procyon Advisors LLC’s holdings in Cardinal Health were worth $4,795,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Redhawk Wealth Advisors Inc. increased its holdings in Cardinal Health by 0.5% in the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after purchasing an additional 48 shares during the period. HF Advisory Group LLC lifted its holdings in Cardinal Health by 0.9% during the 4th quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock worth $1,074,000 after buying an additional 49 shares during the period. Kathmere Capital Management LLC grew its position in shares of Cardinal Health by 1.2% in the 1st quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock valued at $896,000 after buying an additional 49 shares during the last quarter. Hillsdale Investment Management Inc. grew its position in shares of Cardinal Health by 0.9% in the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after buying an additional 50 shares during the last quarter. Finally, V Square Quantitative Management LLC increased its stake in shares of Cardinal Health by 2.6% in the first quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock valued at $423,000 after buying an additional 50 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

CAH stock opened at $235.54 on Monday. The company’s 50-day moving average is $212.35 and its 200-day moving average is $213.05. The stock has a market capitalization of $55.16 billion, a PE ratio of 36.01, a price-to-earnings-growth ratio of 1.16 and a beta of 0.49. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $243.21.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 10.77 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is presently 31.50%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. William Blair started coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating for the company. Citigroup reissued a “buy” rating on shares of Cardinal Health in a research report on Thursday, July 2nd. Bank of America raised their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. JPMorgan Chase & Co. dropped their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Finally, Zacks Research lowered shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $249.13.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.